can glp 1 cause insulin resistance Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: “The Earlier, the Better” in Therapy with Incretin-Based Medicine GLP-1 receptor agonism: a transformative

The first is extracellular matrix biology, where fibroblast culture and rat wound-chamber studies from the Maquart and Simeon groups (1988-2000) reported stimulation of collagen synthesis, sulfated glycosaminoglycan synthesis and small proteoglycan expression, alongside upregulation of matrix metalloproteinase-2 and its tissue inhibitors, a simultaneous increase in both matrix deposition and matrix turnover

For primary weight management, the NICE overweight and obesity management guideline takes precedence

used once per week during radiation therapy

The presence of diabetes did not meaningfully affect these results, suggesting that these benefits were not unique to patients with diabetes. The study included 229 patients with RA and overweight or obesity (BMI 27) who were prescribed a GLP-1 RA between 2018 and 2024